- Cancer Types
Information about risk, prevention, screening, symptoms, diagnosis, treatment, and support for all cancers Cancer A to Z - Cancer Treatment
Cancer Treatment
Information about cancer treatment, including surgery, chemotherapy, radiation therapy, clinical trials, proton therapy, complementary medicine, and cutting edge technologies.
- Risk and Prevention
- Cancer Drugs
- Support
Support
Ways for cancer patients and caregivers to cope with cancer, side effects, nutrition, general cancer support issues, grief/end of life issues, and shared survivor's experiences.
- Healthcare Professionals
- Clinical Trials
My Patient Treatment Binder
OncoLink Blogs
What's My Cancer Risk?
OncoPilot: Navigating Your Cancer Journey
Community Events Calendar
OncoLink eNews
Abramson Cancer CenterProstate Cancer News
 Comorbidities Up Other-Cause Death for Men With Prostate CAMay 22, 2013 Among men with nonmetastatic prostate cancer the risk for other-cause mortality increases with the number of comorbid conditions, particularly in older men, according to a study published in the May 21 issue of the Annals of Internal Medicine. |
 FDA Approves Xofigo for Advanced Prostate CancerMay 17, 2013 The U.S. Food and Drug Administration has approved a drug to help men with advanced prostate cancer whose disease has spread to the bones. |
 Surgeon Variation Affects QoL After ProstatectomyMay 16, 2013 There is a significant association between performing surgeons and patient quality of life following radical prostatectomy, according to a study published in the April issue of The Journal of Urology. |
 AUA: Death Up in Weekend ER Visits for Prostate Cancer PatientsMay 13, 2013 For patients with metastatic prostate cancer, visiting the emergency department over the weekend is associated with increased odds of mortality, according to a study presented at the annual meeting of the American Urological Association, held from May 4 to 8 in San Diego. |
 Obesity Tied to Risk of Prostate Cancer After Negative BiopsyApr 25, 2013 In men with an initial benign biopsy or transurethral resection of the prostate, obesity at the time of the procedure is associated with the presence of precancerous lesions in the initial biopsy and a higher risk of developing prostate cancer, according to a study published online April 23 in Cancer Epidemiology, Biomarkers & Prevention. |
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
